Shares Investor Evening (London)

Shares Investor Evening (London)

Wednesday 13 February 2019

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision makers behind some of the UK’s fastest growing listed companies.

The event on 13 February 2019 in London will include:
Presentations from Directors of companies to be announced
An opportunity for you to talk directly with the Directors and ask your questions about the company’s core strengths and their short & long term business strategy 
Meet fellow investors and share your investing experience
Complimentary drinks and food
More about the companies presenting:

Coro Energy is an oil and gas exploration company focused on delivering long-term production of natural gas. Coro Energy's aim is to become a mid-tier, south east Asian focused exploration and production company. Completed merger of SEHIL and Saffron Energy, integrating teams and assets under Coro Energy.

Destiny Pharma is an innovative pharmaceutical company focused on the development of novel medicines that represent a totally different approach to infectious disease. Destiny Pharma’s XF Drug Platform is being developed to address existing and emerging multi-drug resistant microbial pathogens which cause infections within and outside of hospitals.

St Mark Homes was established in 1999.  In the early years the company undertook EIS qualifying secured contracting trades; the group continues to retain a construction capacity.In 2006 the business expanded its range of operations into mainstream house building and property development.In 2016 we completed the acquisition of St Mark Contracts PLC and raised fresh capital via an open share offer. St Mark undertakes development both in its own right and in joint venture partnership with other established developers.

VolitionRx is a multi-national company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream - an indication that cancer is present.

Who Should Attend

The evening is a perfect opportunity for existing shareholders or potential investors to hear from those that matter, the directors running the companies. Who better to explain the future potential and strategy. 

Evening timings

Registration and coffee
James Menzies, CEO - Coro Energy (CORO)
Neil Clark, CEO - Destiny Pharma (DEST)
Barry Tansey, Chief Executive - St Mark Homes (SMAP)
Cameron Reynolds, President & CEO - VolitionRx
+ More to be announced
Drinks reception and canapés


Novotel Tower Bridge, London EC3N 2NR

Sponsored by

Featured Companies